1.	Phase II Pilot Study of Combination Chemotherapy with 5-FU/THP-Adriamycin/CTX in Patients with Metastatic Breast Cancer (Summary Last Modified 09/88) Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: Protocol IDs: MDA-DM-87008, NCI-V88-0433
2.	Phase II Combination Chemotherapy with THP-Adriamycin/DTIC in Patients with Metastatic or Unresectable Soft Tissue Sarcomas and Gynecologic Sarcomas (Summary Last Modified 05/89) Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: Protocol IDs: MDA-DM-87016, NCI-V88-0434
3.	Phase II Study of Pirarubicin (THP) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 11/88) Phase: Phase II Type: Treatment Status: Closed Age: 75 or less Sponsor: Protocol IDs: EORTC-24873
4.	Phase II Study of Pirarubicin in Patients with Unresectable Malignant Mesothelioma (Summary Last Modified 02/90) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: SCCC-8827, NCI-V89-0309
5.	Phase II Study of Pirarubicin in Patients with Metastatic Adenocarcinoma of the Breast (Summary Last Modified 10/89) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: PCCC-8725, NCI-V89-0137
6.	Phase II Study of Pirarubicin in Patients with Advanced Carcinoma of the Head and Neck (Summary Last Modified 10/89) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: PCCC-8726, NCI-V89-0138
7.	Phase II Study of Pirarubicin in Patients with Advanced non-Small Cell Lung Cancer (Summary Last Modified 10/89) Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: PCCC-8727, NCI-V89-0139